Activation of NF-κB/p65 facilitates early chondrogenic differentiation during endochondral ossification

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Caron, Marjolein M J ^a   Emans, Pieter J ^a   Surtel, Don A M ^a   Cremers, Andy ^a   Voncken, Jan Willem ^b   Welting, Tim J M ^a   van Rhijn, Lodewijk W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SOX9; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN 2; PRIMER DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHICKEN; CHONDROGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EX VIVO STUDY; EXPLANT; GENE EXPRESSION; GROWTH PLATE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERIOSTEUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BONE DEVELOPMENT; CELL LINE; CELL PROLIFERATION; CHICK EMBRYO; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

MUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CELL PROLIFERATION; CHICK EMBRYO; CHONDROGENESIS; DNA PRIMERS; GENE EXPRESSION PROFILING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; OSTEOGENESIS; PERIOSTEUM; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 84858021975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033467     Document Type: Article

References (54)

1. Kronenberg HM, (2003) Developmental regulation of the growth plate. Nature 423: 332-336.
2. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M, (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40: 46-62.
3. Zuscik MJ, Hilton MJ, Zhang X, Chen D, O'Keefe RJ, (2008) Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 118: 429-438.
4. Grundnes O, Reikeras O, (1993) The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64: 340-342.
5. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC, (1995) The expression of cytokine activity by fracture callus. J Bone Miner Res 10: 1272-1281.
6. Mountziaris PM, Mikos AG, (2008) Modulation of the Inflammatory Response for Enhanced Bone Tissue Regeneration. Tissue Eng Part B Rev.
7. Novack DV, (2011) Role of NF-kappaB in the skeleton. Cell Res 21: 169-182.
8. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, et al. (2003) NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278: 29130-29135.
9. Park M, Yong Y, Choi SW, Kim JH, Lee JE, et al. (2007) Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nat Cell Biol 9: 287-298.
10. Wu S, Flint JK, Rezvani G, De Luca F, (2007) Nuclear factor-kappaB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem 282: 33698-33706.
11. Ushita M, Saito T, Ikeda T, Yano F, Higashikawa A, et al. (2009) Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells. Osteoarthritis and cartilage/OARS, Osteoarthritis Research Society 17: 1065-1075.
12. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B, (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828.
13. Lefebvre V, Behringer RR, de Crombrugghe B, (2001) L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 (Suppl A): S69-75.
14. Lefebvre V, de Crombrugghe B, (1998) Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol 16: 529-540.
15. Han Y, Lefebvre V, (2008) L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28: 4999-5013.
16. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B, (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336-2346.
17. Lefebvre V, Li P, de Crombrugghe B, (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17: 5718-5733.
18. Atsumi T, Miwa Y, Kimata K, Ikawa Y, (1990) A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 30: 109-116.
19. Chen L, Fink T, Zhang XY, Ebbesen P, Zachar V, (2005) Quantitative transcriptional profiling of ATDC5 mouse progenitor cells during chondrogenesis. Differentiation 73: 350-363.
20. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
21. Abad V, Meyers JL, Weise M, Gafni RI, Barnes KM, et al. (2002) The role of the resting zone in growth plate chondrogenesis. Endocrinology 143: 1851-1857.
22. Huang W, Zhou X, Lefebvre V, de Crombrugghe B, (2000) Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 20: 4149-4158.
23. Kock LM, Ravetto A, van Donkelaar CC, Foolen J, Emans PJ, et al. (2010) Tuning the differentiation of periosteum-derived cartilage using biochemical and mechanical stimulations. Osteoarthritis Cartilage 18: 1528-1535.
24. Yoon BS, Lyons KM, (2004) Multiple functions of BMPs in chondrogenesis. J Cell Biochem 93: 93-103.
25. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, et al. (2005) BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 23: 411-419.
26. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, et al. (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648.
27. Romas E, Gillespie MT, Martin TJ, (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30: 340-346.
28. Wehling N, Palmer GD, Pilapil C, Liu F, Wells JW, et al. (2009) Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 60: 801-812.
29. Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F, (2008) p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem 104: 1393-1406.
30. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, et al. (2006) Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281: 27229-27241.
31. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ, (2003) Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85-A (Suppl 3): 59-66.
32. Aung A, Gupta G, Majid G, Varghese S, (2011) Osteoarthritic chondrocyte-secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum 63: 148-158.
33. Baldik Y, Diwan AD, Appleyard RC, Fang ZM, Wang Y, et al. (2005) Deletion of iNOS gene impairs mouse fracture healing. Bone 37: 32-36.
34. Diwan AD, Wang MX, Jang D, Zhu W, Murrell GA, (2000) Nitric oxide modulates fracture healing. J Bone Miner Res 15: 342-351.
35. Franchimont N, Durant D, Canalis E, (1997) Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138: 3380-3386.
36. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, et al. (2001) Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169: 285-294.
37. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Tsay A, et al. (2003) Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18: 1584-1592.
38. Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, et al. (2009) Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res 24: 251-264.
39. Rundle CH, Wang H, Yu H, Chadwick RB, Davis EI, et al. (2006) Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 38: 521-529.
40. Simon AM, O'Connor JP, (2007) Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am 89: 500-511.
41. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, et al. (2002) Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109: 1405-1415.
42. Zhu W, Murrell GA, Lin J, Gardiner EM, Diwan AD, (2002) Localization of nitric oxide synthases during fracture healing. J Bone Miner Res 17: 1470-1477.
43. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, et al. (2008) Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294: C675-682.
44. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR, (2006) Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291: R880-884.
45. van der Kraan PM, van den Berg WB, (2007) Osteophytes: relevance and biology. Osteoarthritis Cartilage 15: 237-244.
46. Grau AM, Datta PK, Zi J, Halder SK, Beauchamp RD, (2006) Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells. Cell Signal 18: 1041-1050.
47. Wu S, Fadoju D, Rezvani G, De Luca F, (2008) Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem 283: 34037-34044.
48. Croitoru-Lamoury J, Lamoury FM, Zaunders JJ, Veas LA, Brew BJ, (2007) Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research 27: 53-64.
49. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, et al. (2007) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109: 1422-1432.
50. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, et al. (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
51. Emans PJ, van Rhijn LW, Welting TJ, Cremers A, Wijnands N, et al. (2010) Autologous engineering of cartilage. Proc Natl Acad Sci U S A 107: 3418-3423.
52. Stevens MM, Marini RP, Schaefer D, Aronson J, Langer R, et al. (2005) In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci U S A 102: 11450-11455.
53. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, et al. (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14: 185-196.
54. O'Driscoll SW, Recklies AD, Poole AR, (1994) Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg Am 76: 1042-1051.